Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00344695 · ClinicalTrials.gov registry record · Phase 3
Bupropion Treatment for Youth Smoking Cessation
A Phase 3 study of Nicotine Dependence, sponsored by University of Arizona.
- Completed
- Registry status
- Phase 3
- Development phase
- 1
- Study location
NCT00344695: Completed Phase 3 study of Nicotine Dependence, sponsored by University of Arizona.
NCT00344695 is a Phase 3 study of Nicotine Dependence that has completed, run by University of Arizona. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00344695, a Phase 3 study of Nicotine Dependence, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1
- Study location
Study Summary
The purpose of this study is to 1) evaluate the safety and efficacy of two doses of bupropion SR (150mg/day and 300mg/day) when compared to placebo, as an aid to smoking cessation in adolescents and 2) to examine which factors, such as medication adherence, nicotine dependence, and motivation to quit, affect treatment outcome.
Conditions Studied
Interventions
- DRUG bupropion SR
Study Locations (1)
Arizona
- University of Arizona - Tucson
Trial Details
| Field | Value |
|---|---|
| Est. Completion | 2003-04 |
| Phase | Phase 3 |
What the finished NCT00344695 record still lists
NCT00344695 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 1 condition, with Nicotine Dependence appearing as the primary indexed condition, and to 1 intervention - of which bupropion SR is the first listed.
NCT00344695 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT00344695 about?
NCT00344695 is a clinical study titled "Bupropion Treatment for Youth Smoking Cessation". The purpose of this study is to 1) evaluate the safety and efficacy of two doses of bupropion SR (150mg/day and 300mg/day) when compared to placebo, as an aid to smoking cessation in adolescents and 2) to examine which factors, such as medication adherence, nicotine dependence, and motivation to qui...
What is the current status of trial NCT00344695?
This trial is currently completed. It is a Phase 3 study. Estimated completion is 2003-04.
What conditions does trial NCT00344695 study?
This clinical trial studies the following conditions: Nicotine Dependence.
What interventions are being tested in trial NCT00344695?
The interventions under investigation include: bupropion SR (DRUG).
Who is sponsoring clinical trial NCT00344695?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00344695 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nicotine Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Optimizing Tobacco Use Treatment for PLWHA
RECRUITING · Phase 3
-
Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.
RECRUITING · Phase 3
-
Smoking Treatment in HIV Clinical Care Settings
COMPLETED · Phase 3
-
Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC)
RECRUITING · NA
-
Effects of Cannabidiol on Stress and Nicotine Withdrawal
RECRUITING · Phase 1
-
Overcoming Nicotine Dependence to Enable Quitting
RECRUITING · Phase 1